Evidence for statin therapy in polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age group that is associated with increased cardiovascular risk. In addition to its lipid-lowering effects, statin therapy has shown been shown to have beneficial pleiotropic effects that may contribute to their...
Main Authors: | Thozhukat Sathyapalan, Stephen L. Atkin |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2010-04-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/2042018810367984 |
Similar Items
-
The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence
by: Mohammed Altigani Abdalla, et al.
Published: (2021-01-01) -
Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
by: Huda Alalami, et al.
Published: (2019-01-01) -
Components of the Complement Cascade Differ in Polycystic Ovary Syndrome
by: Alexandra E. Butler, et al.
Published: (2022-10-01) -
A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome
by: Mohammed Altigani Abdalla, et al.
Published: (2020-07-01) -
Pregnancy in polycystic ovary syndrome
by: Sadishkumar Kamalanathan, et al.
Published: (2013-01-01)